stockrowWhat it does
UnitedHealth Group is a health care and well-being company built around two complementary businesses: UnitedHealthcare and Optum. UnitedHealthcare sells health benefits that help employers, individuals, seniors and people enrolled in public programs pay for and access care. It arranges discounted access to physicians, hospitals and other providers through care networks, and uses Optum services to help coordinate care, manage pharmacy benefits and analyze costs.
Optum is the services side of the company. Optum Health delivers primary, specialty and surgical care, care management, home and virtual care, wellness services and health financial services. Optum Insight sells health-care technology, data, analytics, consulting and managed services to hospitals, doctors, health plans, governments and life-sciences companies. Optum Rx manages prescription-drug benefits and provides pharmacy services through retail, home-delivery, specialty and community pharmacies, infusion services and direct-to-consumer offerings.
The company has four reportable segments: UnitedHealthcare, Optum Health, Optum Insight and Optum Rx. It realigned Optum Financial, including Optum Bank, from Optum Health to Optum Insight on January 1, 2026, while retaining the same four reportable segments. Stephen Hemsley is Chair and Chief Executive Officer. The company had 390,000 employees in FY2025.
How it makes money
UnitedHealthcare earns premium revenue in risk-based arrangements, where it takes responsibility for medical and administrative costs in return for a monthly premium. It also earns administrative and management fees when employer customers self-fund employee medical costs while UnitedHealthcare administers benefits, processes transactions and provides access to contracted provider networks. Medicare Advantage revenue includes fixed monthly payments per member from CMS and, in some cases, member premiums. Medicaid and other Community & State programs generally pay a monthly premium per member.
Optum Health earns monthly premiums in fully accountable value-based arrangements, under which it takes responsibility for care costs. It also earns monthly administrative fees and contracted fees for health-related products and medical services. Optum Financial charges fees and earns investment and interest income on managed funds and loans. Optum Insight earns revenue from data, analytics, consulting, technology and managed services; many software and professional-service arrangements extend over several years. Optum Rx earns from pharmacy care services for health-benefits providers, employers, unions, trusts, purchasing coalitions and public-sector entities.
For FY2025, UnitedHealthcare revenue was $344.9 billion and Optum revenue was $270.6 billion; Q2 2026 performance was described by management as in line with its full-year plan at Optum Insight and Medicaid. Products revenue was $53.4 billion and services revenue was $38.0 billion in FY2025. Optum Insight had approximately $31.1 billion of aggregate backlog at December 31, 2025, including $18.3 billion expected within the following 12 months.
| Product or service | Revenue, FY2025 | Share | Change on the year |
|---|---|---|---|
| Products | $53.4 billion | 58.4% | 6.28% |
| Services | $38.0 billion | 41.6% | 5.54% |
Customers and how it sells
UnitedHealthcare serves employer groups, public-sector employers, small businesses, individuals, seniors and other Medicare-eligible consumers, and people covered by Medicaid and related public programs. Employer & Individual provided access to medical services for 29.7 million people at December 31, 2025. Medicare & Retirement served 8.4 million people through Medicare Advantage products, enrolled 10.4 million people in Medicare Part D programs and served 4.3 million seniors through Medicare Supplement products. Community & State participated in programs in 32 states and the District of Columbia and served nearly 7.4 million people.
Optum serves patients and consumers, care providers, payers, employers, governments and life-sciences companies. Optum Health addresses the well-being of 95 million consumers and serves more than 100 health-payer partners. Optum Rx serves health-benefits providers, large employers, unions and trusts, purchasing coalitions and public-sector entities through approximately 64,000 retail pharmacies, home delivery, specialty and community pharmacies, and infusion services.
The business participates primarily in U.S. health markets, although certain operations are international. Premium revenue from CMS represented 44% of total consolidated revenue in FY2025, with most generated by UnitedHealthcare Medicare & Retirement. UnitedHealthcare distributes through direct sales, consultants, brokers, agents, agencies, employer organizations and exchange marketplaces, depending on the product. Optum businesses use direct sales forces, collaborations, producers, brokers, consultants, alliances and technology partnerships.
| Segment | Revenue, FY2025 | Share | Change on the year |
|---|---|---|---|
| UnitedHealthcare | $344.9 billion | 38.7% | 15.7% |
| Optum | $270.6 billion | 30.4% | 6.98% |
| Optum Rx | $154.7 billion | 17.4% | 16.1% |
| Optum Health | $102.0 billion | 11.4% | −3.23% |
| Optum Insight | $19.4 billion | 2.18% | 3.52% |
Suppliers and costs
Medical costs are the central operating cost for UnitedHealthcare’s risk-based benefits and Optum Health’s fully accountable care arrangements. The company depends on contracts with physicians, hospitals, pharmaceutical benefit service providers, pharmaceutical manufacturers and other care and service providers at competitive prices. Provider market power, higher payment demands and provider contracting decisions can affect medical costs, product design and network adequacy.
Medical costs are affected by the number, type and unit cost of services, as well as pharmacy spending. The company identified medical-cost inflation, service use, provider billing intensity, new or costly drugs, drug-price increases, treatment changes and mandated benefits as factors that can cause actual costs to exceed pricing assumptions. Management said on the Q2 2026 call that commercial trends were modestly above 11%, citing the No Surprises Act independent-resolution process, provider coding intensity, specialty-drug costs and care patterns.
Optum Rx managed $188 billion in pharmaceutical spending in 2025, including nearly $87 billion in specialty pharmaceutical spending. The company also has technology, workforce and compliance costs, and said its value-based-care transition requires system enhancements, care-coordination technology, physician training and clinical engagement.
- Revenue$447.6B
- Cost of revenue−$364.7B
- Other operating costs−$64.0B
- Operating income$19.0B
Competitive position
UnitedHealth Group operates in competitive health-benefits, care-delivery, pharmacy-services and health-care technology markets. It competes on product and service innovation, technology, consumer and provider engagement, service, sales, marketing, pricing, network relationships and medical and operating cost positions. The company also faces competition from startups, for-profit and non-profit companies, private and government-sponsored entities, and larger enterprises. New entrants, supplier combinations and consolidation among competitors can affect customer retention, supplier terms and profitability.
UnitedHealthcare identifies local-market relationships, breadth of benefit offerings, service and digital consumer engagement, cost positions, clinical engagement and innovation as elements of its market position. Its networks and Optum capabilities support care coordination, affordability analysis, pharmacy services and provider engagement. Optum’s data, analytics, clinical capabilities, care delivery, pharmacy network and technology offerings serve different participants in the health system.
Our reading: Provider networks, data and analytics, and the connection between UnitedHealthcare and Optum are meaningful operating advantages because they support benefit administration, care delivery and pharmacy services across the same health system participants; their durability depends on maintaining provider, payer and customer relationships. [item1; item1a]
Our reading: The company’s moat is limited by regulated pricing and benefits, active competition across every business line, and the ability of providers, payers and new technology entrants to change the terms of competition. [item1; item1a]
No individual competitor is named as competing with UnitedHealth Group in the available business descriptions.
Growth opportunities
The company’s growth efforts center on expanding and modernizing health benefits, value-based care, pharmacy services and health-care technology. It seeks to move care and payment from fee-for-service models toward fully accountable value-based arrangements, where payment is tied to managing care costs and outcomes. The company expects health-care spending to continue growing because of inflation, medical technology and pharmaceutical advances, regulatory requirements, demographic trends and interest in health and well-being.
Optum Health is expanding clinical, in-home, virtual and digital care capabilities. Management said on the Q2 2026 call that Optum Health serves 20,000,000 people through primary and specialist care, ambulatory surgery and home health, reaches nearly 90% of U.S. counties and conducts approximately 2,500,000 rural patient home visits. Management also said that care-management work in one region was producing about a 10% reduction in inpatient admissions.
Optum Insight is investing in technology and services for health-system administration, payment integrity, clinical workflows and care quality. Management said on the Q2 2026 call that AI-enabled coding, real-time payer-provider interfaces and clinical quality and safety support were gaining customer traction. Management said its Optum Real digital prior-authorization product had processed about half a million prior authorizations and saved 69,000 administrative hours year to date. Management also reported early Value Connect client results including a 17% reduction in pharmacy costs.
The company expects Medicare Advantage membership and the number of people served in value-based arrangements to contract in 2026 amid funding pressures, benefit and pricing actions.
- $287.6BFY2021
- $324.2BFY2022
- $371.6BFY2023
- $400.3BFY2024
- $447.6BFY2025
Structural risks
- Medical-cost pricing and estimation. Risk-based products account for nearly 80% of total consolidated revenue. Small differences between predicted and actual medical costs or utilization can materially change results, while fixed-premium periods can limit recovery of higher costs.
- Government funding and regulation. Medicare Advantage and Medicaid payments, benefits, risk adjustment, audits and state contracts are regulated. Medicare funding pressure, rate changes and Medicaid reimbursement rates that lag medical-cost trends can reduce margins or require benefit, network and pricing changes.
- Data, technology and cybersecurity. The business depends on timely, accurate health data and information systems. Cyberattacks, data incidents, system failures, defective technology products, AI-related errors and integration failures can disrupt operations, create liability and damage relationships.
- Provider, pharmacy and payer relationships. The company depends on physicians, hospitals, pharmacies, manufacturers, payer partners and other providers. Higher provider payments, network disputes, provider consolidation, inability to retain physicians, or inadequate performance by risk-bearing providers can increase costs or disrupt care.
- Competition and execution. Competition, new entrants, consolidation and changing customer needs can pressure enrollment, pricing, supplier terms and market share. The company must develop and deliver relevant benefit, care, technology and value-based-care offerings.
- Legal and compliance exposure. The business is routinely subject to governmental investigations and private legal actions involving benefit coverage, claims, care delivery, data practices, technology products, contracting, antitrust and pharmacy operations.
Bottom line
Our reading
Our reading: UnitedHealth Group combines a regulated health-benefits business with care delivery, pharmacy services and health-care technology, so its results depend heavily on pricing medical costs, government program funding and provider relationships. [item1; item1a; item7]
Our reading: The Optum businesses provide service revenue streams and operational links to UnitedHealthcare, but value-based care, technology modernization and AI deployment also require execution, data integrity and clinical-cost discipline. [item1; item1a; call_prepared]
Our reading: Commercial medical-cost pressure, Medicare funding conditions and Medicaid reimbursement timing remain material constraints on those operations. [item7; call_qa]